Behrman acquires unit from Elan

US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this